What is Amlyze?
AMLYZE provides a comprehensive suite of compliance tools focused on anti-money laundering (AML) and counter-financing of terrorism (CFT) solutions. Developed by former regulators and industry experts, their platform offers transaction monitoring, customer risk assessment, AML investigations, and customer screening. The company aims to reduce false positives and enhance efficiency in compliance processes for banks, fintechs, crypto businesses, and other financial institutions. AMLYZE's cloud-native platform is designed to ensure regulatory adherence and effective risk mitigation, positioning it as an innovative force in compliance technology.
How much funding has Amlyze raised?
Amlyze has raised a total of $3.6M across 2 funding rounds:
Other Financing Round
$1M
Angel/Seed
$2.6M
Other Financing Round (2023): $1M with participation from Practica Capital
Angel/Seed (2024): $2.6M led by Firstpick, Practica Capital, Coinvest Capital, and Advanzia Bank
Key Investors in Amlyze
Firstpick
Firstpick is a leading provider of packing and moving services in India, specializing in both residential and commercial relocations. They offer a comprehensive range of services including local, domestic, and international moving, as well as storage solutions, ensuring a hassle-free experience for their clients.
Practica Capital
Practica Capital is a venture capital firm focused on backing entrepreneurs through various stages of funding, including seed and series A investments. With over 132 million euros under management, the firm has made more than 70 investments across diverse sectors such as biotech, fintech, and e-commerce.
Coinvest Capital
Coinvest Capital is a venture capital fund that co-invests with business angels and other private funds in startups, focusing on enhancing the startup ecosystem in Lithuania. With a committed capital of EUR 44.3 million, the fund aims to fill funding gaps and strengthen the business angel community by investing in sectors of strategic importance.
What's next for Amlyze?
The recent major enterprise-level funding indicates Amlyze is poised for significant scaling and expansion. This capital injection will likely fuel further development of their AML/CFT solutions, enhance their market reach, and potentially support strategic acquisitions or partnerships. The company's focus on improving efficiency and reducing false positives in compliance processes positions it well to capitalize on the increasing regulatory scrutiny faced by financial institutions globally.
See full Amlyze company page
